Wealthcare Advisory Partners’s Astera Labs ALAB Stock Holding History

Wealthcare Advisory Partners’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11M	Buy	22,845 +201	+0.9%	+$53.3K	0.21%	95
2026 Q1	$2.48M	Sell	22,644 -5,910	-21%	-$842K	0.05%	321
2025 Q4	$4.75M	Sell	28,554 -319	-1%	-$53.4K	0.09%	194
2025 Q3	$5.65M	Sell	28,873 -287	-1%	-$47.2K	0.12%	152
2025 Q2	$2.64M	Buy	29,160 +221	+0.8%	+$17.5K	0.06%	269
2025 Q1	$1.73M	Buy	28,939 +320	+1%	+$29.6K	0.05%	317
2024 Q4	$3.79M	Buy	28,619 +704	+3%	+$66.1K	0.11%	167
2024 Q3	$1.46M	Buy	27,915 +4,619	+20%	+$217K	0.04%	329
2024 Q2	$1.41M	Buy	+23,296	New	+$1.62M	0.04%	303

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wealthcare Advisory Partners's ALAB Position: Q2 2026 in Review

Wealthcare Advisory Partners increased its Astera Labs (ALAB) stake by 0.89% in Q2 2026, buying an estimated $53.3K and bringing the position to 22,845 shares worth $11M. The position accounts for 0.21% of the portfolio, ranked #95.

Wealthcare Advisory Partners first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Wealthcare Advisory Partners held 22,845 shares of Astera Labs worth $11M as of Q2 2026.
Wealthcare Advisory Partners bought 201 Astera Labs shares in Q2 2026, an estimated $53.3K.
Astera Labs made up 0.21% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #95 holding.
Wealthcare Advisory Partners first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.